Econtra One-Step Emergency Contraceptive Tablet, 1.5 mg

Econtra One-Step Emergency Contraceptive Tablet, 1.5 mg Econtra One-Step provides rapid, effective emergency contraception with a single-dose formulation containing 1.5 mg of levonorgestrel, a progestin-only emergency contraceptive agent. This medication is designed for use following unprotected intercourse or contraceptive failure, offering maximum efficacy when administered within 72 hours of sexual contact, with continued effectiveness up to 120 hours. The one-tablet regimen eliminates dosing complexity and improves compliance compared to multi-dose protocols, ensuring consistent therapeutic delivery. Levonorgestrel functions by delaying or inhibiting ovulation, preventing fertilization and reducing pregnancy risk by approximately 60-90% depending on timing of administration. The formulation is available without age restrictions and does not require prescription in most jurisdictions, ensuring accessible emergency reproductive healthcare. Econtra One-Step is well-tolerated with minimal systemic side effects, though temporary menstrual cycle alterations may occur. The medication does not interrupt established pregnancy and carries no teratogenic risk. Suitable for individuals seeking reliable, time-sensitive contraceptive intervention following unplanned sexual exposure. An essential medication for emergency reproductive health management, recommended by healthcare providers and reproductive health organizations worldwide for rapid, evidence-based pregnancy prevention.